Trademark: 98232757
Word
CYTEGRITY
Status
Pending
Status Code
641
Status Date
Thursday, June 13, 2024
Serial Number
98232757
Mark Type
4
Filing Date
Friday, October 20, 2023

Trademark Owner History

Classifications
5 Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for gene therapy; gene therapy vectors
1 Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines; cell lines for gene expression, and for synthesis of biological compounds; cells for gene expression and for synthesis of biological compounds; viral vectors

Trademark Events
Oct 24, 2023
New Application Entered
Oct 25, 2023
New Application Office Supplied Data Entered
Jun 5, 2024
Assigned To Examiner
Jun 13, 2024
Non-Final Action E-Mailed
Jun 13, 2024
Non-Final Action Written
Jun 13, 2024
Notification Of Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24